We determined the effect of BA on diabetes-mediated GLUT4 suppression in muscles and found that STZ/VEH treatment significantly reduced GLUT4 expression of both mRNA (Figure 4a) and protein levels (Figures 4b, c and S1d, see online supplementary material) compared to the CTL/VEH group. The gene discussed is SLC2A4; the disease is diabetes mellitus.